Amphastar Pharmaceuticals (AMPH) Change in Inventory (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) recorded quarterly Change in Inventory of -$6.2 million in Q1 2026, up 30.65% quarter-over-quarter from -$9.0 million in Q4 2025, and down 120.08% on a YoY basis from $31.1 million in Q1 2025.
Amphastar Pharmaceuticals (AMPH) Change in Inventory (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Change in Inventory history runs 14 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 120.08% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$16.3 million (down 123.31% YoY), while the FY2025 annual figure was $21.1 million, down 56.84% from the prior year.
- Change in Inventory was -$6.2 million for Q1 2026 at Amphastar Pharmaceuticals, up from -$9.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $31.1 million in Q1 2025 to a low of -$9.0 million in Q4 2025.
- Historically, Change in Inventory has averaged $4.5 million across 5 years, with a median of $4.7 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory tumbled 309.27% in 2023, then jumped 3829.48% in 2024.
- A 5-year view of Change in Inventory shows it stood at -$1.2 million in 2022, then tumbled by 309.27% to -$4.8 million in 2023, then surged by 608.37% to $24.5 million in 2024, then plunged by 136.82% to -$9.0 million in 2025, then surged by 30.65% to -$6.2 million in 2026.
- The last three Change in Inventory figures came in at -$6.2 million (Q1 2026), -$9.0 million (Q4 2025), and -$5.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -93.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 114.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -4.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 20.30 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -2.11 Mn |
| 10 | Amphastar Pharmaceuticals | 914.14 Mn | 914.14 Mn | 70.32 Mn | -6.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.25 Mn |
| Mar 31, 2026 | -6.25 Mn |
| Dec 31, 2025 | -9.01 Mn |
| Dec 31, 2025 | -9.01 Mn |
| Sep 30, 2025 | -5.86 Mn |
| Sep 30, 2025 | -5.86 Mn |
| Jun 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | 4.82 Mn |
| Mar 31, 2025 | 31.11 Mn |
| Mar 31, 2025 | 31.11 Mn |
| Dec 31, 2024 | 24.47 Mn |
| Dec 31, 2024 | 24.47 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Dec 31, 2023 | -4.81 Mn |
| Dec 31, 2023 | -4.81 Mn |